These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1960381)
1. A comparison of fluoxetine and amitriptyline in the treatment of major depression. Keegan D; Bowen RC; Blackshaw S; Saleh S; Dayal N; Remillard F; Shrikhande S; Cebrian Perez S; Boulton A Int Clin Psychopharmacol; 1991; 6(2):117-24. PubMed ID: 1960381 [TBL] [Abstract][Full Text] [Related]
2. Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. Altamura AC; De Novellis F; Guercetti G; Invernizzi G; Percudani M; Montgomery SA Int J Clin Pharmacol Res; 1989; 9(6):391-6. PubMed ID: 2699465 [TBL] [Abstract][Full Text] [Related]
3. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Chouinard G J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679 [TBL] [Abstract][Full Text] [Related]
4. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Feighner JP J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204 [TBL] [Abstract][Full Text] [Related]
5. A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness. Judd FK; Moore K; Norman TR; Burrows GD; Gupta RK; Parker G Aust N Z J Psychiatry; 1993 Mar; 27(1):49-55. PubMed ID: 8481170 [TBL] [Abstract][Full Text] [Related]
6. Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison. Versiani M; Ontiveros A; Mazzotti G; Ospina J; Dávila J; Mata S; Pacheco A; Plewes J; Tamura R; Palacios M Int Clin Psychopharmacol; 1999 Nov; 14(6):321-7. PubMed ID: 10565798 [TBL] [Abstract][Full Text] [Related]
7. Fluoxetine versus amitriptyline in the treatment of major depression: a multicenter trial. Beasley CM; Sayler ME; Potvin JH Int Clin Psychopharmacol; 1993; 8(3):143-9. PubMed ID: 8263311 [TBL] [Abstract][Full Text] [Related]
8. Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline. Richardson JS; Keegan DL; Bowen RC; Blackshaw SL; Cebrian-Perez S; Dayal N; Saleh S; Shrikhande S Int Clin Psychopharmacol; 1994; 9(1):35-40. PubMed ID: 8195581 [TBL] [Abstract][Full Text] [Related]
9. A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. Young JP; Coleman A; Lader MH Br J Psychiatry; 1987 Sep; 151():337-40. PubMed ID: 3322468 [TBL] [Abstract][Full Text] [Related]
10. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline. Marchesi C; Ceccherininelli A; Rossi A; Maggini C Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635 [TBL] [Abstract][Full Text] [Related]
11. Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. Demyttenaere K; Van Ganse E; Gregoire J; Gaens E; Mesters P Int Clin Psychopharmacol; 1998 Jan; 13(1):11-7. PubMed ID: 9988362 [TBL] [Abstract][Full Text] [Related]
12. A double-blind study of minaprine versus amitriptyline in major depression. Del Zompo M; Bernardi F; Burrai C; Bocchetta A Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline. Altamura AC; Percudani M; Guercetti G; Invernizzi G Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():103-6. PubMed ID: 2783697 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. Reimherr FW; Chouinard G; Cohn CK; Cole JO; Itil TM; LaPierre YD; Masco HL; Mendels J J Clin Psychiatry; 1990 Dec; 51 Suppl B():18-27. PubMed ID: 2258378 [TBL] [Abstract][Full Text] [Related]
15. Fluoxetine in major depression: efficacy, safety and effects on sleep polygraphic variables. Kerkhofs M; Rielaert C; de Maertelaer V; Linkowski P; Czarka M; Mendlewicz J Int Clin Psychopharmacol; 1990 Oct; 5(4):253-60. PubMed ID: 2081896 [TBL] [Abstract][Full Text] [Related]
16. Economic appraisal of citalopram in the management of single-episode depression. Sclar DA; Skaer TL; Robison LM; Galin RS J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508 [TBL] [Abstract][Full Text] [Related]
17. Fluoxetine vs amitriptyline in the treatment of depressed out-patients. Laakmann G; Blaschke D; Engel R; Schwarz A Br J Psychiatry Suppl; 1988 Sep; (3):64-8. PubMed ID: 3074868 [No Abstract] [Full Text] [Related]
18. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients. Diaz A; Fouilloux C; Ortiz S Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564 [No Abstract] [Full Text] [Related]
19. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients. Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease. Taragano FE; Lyketsos CG; Mangone CA; Allegri RF; Comesaña-Diaz E Psychosomatics; 1997; 38(3):246-52. PubMed ID: 9136253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]